Medtronic Positioned for Spine’s Tech Turn

Medtronic reported FY 4Q23 orthopedic sales of $854.3 million, +2.9% compared to 4Q22. For the full fiscal year, the company amassed orthopedic sales of $3.2 billion, +0.5% compared to the prior year.

Procedure volume recovery and supply improvements drove the growth. However, volume-based procurement in China, inflation and foreign...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us